Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 31 - 40 of 202 for excel. (0.16 seconds)

PPD, the US-based CRO, opened a central laboratory in...
Hua Medicine of Shanghai reported that its lead program,...
Guangzhou MaxiNovel Pharma has been granted Orphan Drug...
Suzhou Alphamab was granted CFDA approval of an IND for...
Alphamab Oncology of Suzhou has started a Phase I...
The Director of the US FDA's Oncology Center of...
Jiangsu Hengrui Medicine entered a $165 million agreement...
Harbour BioMed, a Suzhou-Shanghai biopharma, reported...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here